Marc C Nicklaus

This inventor holds 4 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of. Active years: 1997-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc C Nicklaus. Retrieved from https://idiyas.com/inventor/marc-c-nicklaus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 27(Granted Patents)

Company Filing History:

3 out of 1,217

The United States of America as Represented by the Department of Health

patents

1 out of 2,202

The United States of America as Represented by the Secretary of

patents

Years Active: 1997-1999

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5874464 - Conformationally constrained diacylglycerol analogues (1999-02-23),

2. 5869666 - Conformationally locked nucleoside analogues (1999-02-09),

3. 5840728 - Conformationally locked nucleoside analogs as antiherpetic agents (1998-11-24),

4. 5629454 - Conformationally locked nucleoside analogues (1997-05-13),

Title: The Innovations of Marc C Nicklaus

Introduction

Marc C Nicklaus is a notable inventor based in Elkridge, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 4 patents, his work has had a considerable impact on therapeutic agents.

Latest Patents

Among his latest patents are "Conformationally constrained diacylglycerol analogues" and "Conformationally locked nucleoside analogues." The first patent focuses on pharmaceutical compositions that utilize these analogues as agonists and antagonists of protein kinase C. The second patent involves the preparation of nucleoside analogues that are therapeutically useful as antimetabolites, achieved by condensing cyclopropane-fused carbocyclic allylic alcohol with substituted purine or pyrimidine bases.

Career Highlights

Marc has worked with esteemed organizations, including the United States of America as Represented by the Department of Health. His contributions have been pivotal in advancing pharmaceutical research and development.

Collaborations

Throughout his career, Marc has collaborated with notable individuals such as Victor E Marquez and Juan B Rodriguez. These partnerships have further enriched his work and expanded the scope of his innovations.

Conclusion

Marc C Nicklaus exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]